Dr. Hildebrand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2150 Pennsylvania Ave NW
Washington, DC 20037Phone+1 202-741-3000
Education & Training
- University of Kansas School of MedicineClass of 2022
Certifications & Licensure
- DC State Medical License 2022 - 2025
Publications & Presentations
PubMed
- 126 citationsPreliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-wor...Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden
Hepatology. 2022-10-01 - 10 citationsPatterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.Rohini Sharma, Anjana Pillai, Thomas Urban Marron, Petros Fessas, Anwaar Saeed
Hepatology Communications. 2022-07-01 - 27 citationsIntegrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity sc...Brett Marinelli, Edward Kim, Antonio D'Alessio, Mario Cedillo, Ishan Sinha
Journal for Immunotherapy of Cancer. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: